These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 26267665)

  • 21. Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis.
    Crescenzo F; Marastoni D; Zuco C; Pitteri M; Magliozzi R; Monaco S; Calabrese M
    Mult Scler Relat Disord; 2019 Jan; 27():305-311. PubMed ID: 30453199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes.
    Ceccarelli A; Rocca MA; Pagani E; Colombo B; Martinelli V; Comi G; Filippi M
    Neuroimage; 2008 Aug; 42(1):315-22. PubMed ID: 18501636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis.
    Riccitelli G; Rocca MA; Pagani E; Martinelli V; Radaelli M; Falini A; Comi G; Filippi M
    Mult Scler; 2012 Jul; 18(7):1027-37. PubMed ID: 22422807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
    Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
    Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis.
    Mesaros S; Rovaris M; Pagani E; Pulizzi A; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2008 Sep; 65(9):1223-30. PubMed ID: 18779427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical and Subcortical Gray Matter Volume in Youths With Conduct Problems: A Meta-analysis.
    Rogers JC; De Brito SA
    JAMA Psychiatry; 2016 Jan; 73(1):64-72. PubMed ID: 26650724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spatial Correlation of Pathology and Perfusion Changes within the Cortex and White Matter in Multiple Sclerosis.
    Mulholland AD; Vitorino R; Hojjat SP; Ma AY; Zhang L; Lee L; Carroll TJ; Cantrell CG; Figley CR; Aviv RI
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):91-96. PubMed ID: 29097413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of cortical grey matter thickness reduction in multiple sclerosis.
    Fujimori J; Fujihara K; Wattjes M; Nakashima I
    Brain Behav; 2021 Apr; 11(4):e02050. PubMed ID: 33506628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epilepsy in multiple sclerosis: The role of temporal lobe damage.
    Calabrese M; Castellaro M; Bertoldo A; De Luca A; Pizzini FB; Ricciardi GK; Pitteri M; Zimatore S; Magliozzi R; Benedetti MD; Manganotti P; Montemezzi S; Reynolds R; Gajofatto A; Monaco S
    Mult Scler; 2017 Mar; 23(3):473-482. PubMed ID: 27260699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anosmia leads to a loss of gray matter in cortical brain areas.
    Bitter T; Gudziol H; Burmeister HP; Mentzel HJ; Guntinas-Lichius O; Gaser C
    Chem Senses; 2010 Jun; 35(5):407-15. PubMed ID: 20231262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What explains gray matter atrophy in long-standing multiple sclerosis?
    Steenwijk MD; Daams M; Pouwels PJ; Balk LJ; Tewarie PK; Killestein J; Uitdehaag BM; Geurts JJ; Barkhof F; Vrenken H
    Radiology; 2014 Sep; 272(3):832-42. PubMed ID: 24761837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
    Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes.
    Rocca MA; Colombo B; Falini A; Ghezzi A; Martinelli V; Scotti G; Comi G; Filippi M
    Lancet Neurol; 2005 Oct; 4(10):618-26. PubMed ID: 16168930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
    Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis.
    Meijboom R; York EN; Kampaite A; Harris MA; White N; Valdés Hernández MDC; Thrippleton MJ; MacDougall NJJ; Connick P; Hunt DPJ; Chandran S; Waldman AD;
    PLoS One; 2023; 18(7):e0288967. PubMed ID: 37506096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
    Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; Kappos L; Matthews PM; Nichols TE; Radue EW; Borgwardt SJ
    Neuroimage; 2009 Mar; 45(1):60-7. PubMed ID: 19013533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.
    Cao Y; Diao W; Tian F; Zhang F; He L; Long X; Zhou F; Jia Z
    Neuropsychol Rev; 2021 Dec; 31(4):703-720. PubMed ID: 33582965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional but not global brain damage contributes to fatigue in multiple sclerosis.
    Rocca MA; Parisi L; Pagani E; Copetti M; Rodegher M; Colombo B; Comi G; Falini A; Filippi M
    Radiology; 2014 Nov; 273(2):511-20. PubMed ID: 24927473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gray matter atrophy is associated with functional connectivity reorganization during the Paced Auditory Serial Addition Test (PASAT) execution in Multiple Sclerosis (MS).
    Baltruschat SA; Ventura-Campos N; Cruz-Gómez ÁJ; Belenguer A; Forn C
    J Neuroradiol; 2015 Jun; 42(3):141-9. PubMed ID: 25857687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression of regional grey matter atrophy in multiple sclerosis.
    Eshaghi A; Marinescu RV; Young AL; Firth NC; Prados F; Jorge Cardoso M; Tur C; De Angelis F; Cawley N; Brownlee WJ; De Stefano N; Laura Stromillo M; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Geurts JJG; Vrenken H; Wottschel V; Leurs CE; Uitdehaag B; Pirpamer L; Enzinger C; Ourselin S; Gandini Wheeler-Kingshott CA; Chard D; Thompson AJ; Barkhof F; Alexander DC; Ciccarelli O
    Brain; 2018 Jun; 141(6):1665-1677. PubMed ID: 29741648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.